Health In Tech, Inc. (NASDAQ: HIT) drew fresh scrutiny from Wall Street last week after Maxim Group issued a detailed earnings forecast stretching through fiscal 2027, projecting continued net losses
Health in tech
Health In Tech, Inc. (NASDAQ: HIT) drew fresh scrutiny from Wall Street last week after Maxim Group issued a detailed earnings forecast stretching through fiscal 2027, projecting continued net losses